1- Saudi Consensus Recommendations on the Management of Multiple Sclerosis:
Disease-Modifying Therapies and Management of Relapses December 2022
Clinical and Translational Neuroscience 6(4): 27
2- Saudi Consensus Recommendations on the Management of Multiple Sclerosis:
Symptom Management and Vaccination
Clin. Transl. Neurosci. 2023, 7(1), 6; https://doi.org/10.3390/ctn7010006
3- Association between obesity during different age periods and multiple sclerosis in
Saudi Arabia: A multi-center case-control study April 2022Neurosciences
27(2):87-93
4- Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia November 2021
Multiple Sclerosis International 2021(2):1-6
5- Registry of patients with multiple sclerosis and COVID-19 infection in Saudi Arabia
May 2021 Multiple Sclerosis and Related Disorders 52(4):103004
6- Real-world retrospective study of effectiveness and safety of Fingolimod in relapsing
remitting multiple sclerosis in the Middle East and North Africa (FINOMENA)
February 2021 Clinical Neurology and Neurosurgery 203:106576
7- Familial aggregation of multiple sclerosis: Results from the national registry of the
disease in Saudi Arabia October 2020 Multiple Sclerosis Journal – Experimental
Translational and Clinical 6(4):205521732096049
8- Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study
February 2020 BMC Neurology 20(1)
9- Environmental exposures and the risk of multiple sclerosis in Saudi Arabia
June 2018 BMC Neurology 18(1):86
10- Neuromyelitis Optica Spectrum Disorder: A Rare Case of Transverse Myelitis and
Autonomic Dysfunction DOI: 10.7759/cureus.38791
11- The Saudi Arabian National Multiple Sclerosis Registry (NMSR): Initial Results
Saudi MS Registry Study Group* (P2.390) | Neurology:
https://www.neurology.org/doi/10.1212/WNL.90.15_supplement.P2.390